Ensign Peak Advisors, Inc Syros Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $31,049 - $54,450	-45,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$3.26 - $4.66 $179,300 - $256,300	-55,000 Reduced 55.0%	45,000 $147,000
Q1 2021 May 12, 2021	BUY	$7.19 - $14.95 $719,000 - $1.5 Million	100,000 New	100,000 $748,000
Q4 2020 Feb 12, 2021	SELL	$6.66 - $14.66 $173,020 - $380,852	-25,979 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.69 - $14.47 $225,757 - $375,916	25,979 New	25,979 $230,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.